As one of the seven inaugural national Centres of Excellence in Commercialization and Research (CECR), the Montreal Neurological Institute and Hospital (The Neuro) at McGill University is developing projects with direct impact on advancing health care and with high potential as important commercial ventures.
“The CECR funding has allowed us to start up some high-risk, highly innovative projects, and already we have as a result many successes,” Dr. David Colman, Director of The Neuro, said. “As examples, we have made great progress on new automated devices to detect lesions in drug-resistant epilepsy, as well as advances in ‘targeted medicine’ that include a new diagnostic laboratory providing faster and cheaper access to genetic testing,” he said.